PharmaShell® is based on the Atomic Layer Deposition (ALD) technology to enclose drug particles with an extremely thin and dense inorganic coating. The size distribution of the particles and the thickness distribution of the coating lead to slow and continuous release of the active pharmaceutical ingredient (API) into the bloodstream as the coating dissolves. The thickness of the coating can be controlled with atomic level precision, enabling controlled release over days, weeks, or even months. By replacing traditionally administered treatments with long-acting injectables based on PharmaShell, it is possible to reduce healthcare costs, increase compliance and ultimately enable smarter care.
